CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes Chief Commercial Officer gave up 3,802 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 7,792 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 8,420 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 16,905 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 7,802 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $4.71 ($9,410)
- DEFA14A Proxy Proxy Materials
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Material agreement
- 4 Option exercise Director acquired 37,500 shares (option exercise)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 19 of 41 · 802 filings